MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The changes in activities of daily livings after deep brain stimulation in Parkinson’s disease

    T. Yamamoto, M. Suzuki, S. Hirano, Y. Yamanaka, A. Sugiyama, N. Araki, Y. Higuchi, S. Kuwabara (Chiba, Japan)

    Objective: We aimed to clarify long-term changes in activities of daily living in patients with Parkinson's disease (PD) who underwent deep brain stimulation (DBS). Background:…
  • 2022 International Congress

    MoCA and MMSE subitems’ sensitivity across the PD-cognitive spectrum

    E. Fiorenzato, L. Zurlo, C. Cianci, M. Garon, T. Gandolfi, F. Pistonesi, L. Weis, A. Antonini, R. Biundo (Padua, Italy)

    Objective: To determine which Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) subitems are more sensitive in detecting cognitive abnormalities in patients with PD…
  • 2022 International Congress

    Blood microRNA-7 as a Progression Biomarker in Parkinson’s disease

    M. Doursout, C. Adams, J. Suescun, K. Block, E. Tharp, T. Ellmore, M. Schiess (Houston, USA)

    Objective: This study investigates the use of microRNA-7-5p (miR-7-5p) as a potential biomarker for Parkinson’s disease (PD) progression. Background: MiR-7-5 is a microRNA that regulates…
  • 2022 International Congress

    Safety and efficacy of treadmill training combined with music on motor outcomes in patients with Parkinson’s disease: A systematic review.

    M. Shahien, A. Azzam, A. Ramadan, D. Hasan, A. Elaraby (Cairo, Egypt)

    Objective: To evaluate the efficacy and safety of the treadmill plus music combined rehabilitation training on motor outcomes in participants with Parkinson’s disease. Background: Parkinson’s…
  • 2022 International Congress

    Long-term wearable tele-rehabilitation of gait for persons with Parkinson’s disease: A feasibility study

    G. Lopane, M. Corzani, I. D'Ascanio, V. Petrone, M. Contin, G. Calandra Buonaura, P. Cortelli, F. La Porta, M. Brozgol, N. Giladi, PC. Thumm, JM. Hausdorff, L. Chiari, L. Palmerini (Bologna, Italy)

    Objective: This study aims to evaluate the feasibility of long-term wearable tele-rehabilitation of gait in people with Parkinson’s disease. Background: Tele-rehabilitation allows patients to utilize…
  • 2022 International Congress

    The cross-talk between microglia-derived exosomes and brain printing biometrics as a diagnostic approach for Parkinson’s disease prior to motor symptoms implications

    M. Anwar, M. Fathi (Cairo, Egypt)

    Objective: To highlight the efficiency of using microglia-derived exosomes (MDEs) in cross-talk with the BPB technique for the early diagnosis of Parkinson’s disease (PD) Background:…
  • 2022 International Congress

    Lateral shifting from apomorphine subcutaneous infusion (ASI) to levodopa-carbidopa intestinal gel (LCIG) in the treatment of advanced idiopathic Parkinson’s disease (PD): Case series

    M. Abu Al-Melh, M. Farghal, N. Abdelall (Ahmadi governorate, Kuwait)

    Objective: To report our experience with transitioning from apomorphine subcutaneous infusion (ASI) to levodopa-carbidopa intestinal gel (LCIG) in two patients with advanced idiopathic Parkinson’s disease (PD). Background: Device-assisted…
  • 2022 International Congress

    Correlation between cognitive/emotional factors and postural control in patients with Parkinson’s disease

    A. Bitiati, C. de Oliveira, C. de Souza, A. Batista, R. Marquesini, A. Moreira-Neto, C. Batista, L. Teixeira, A. Pardini, D. Coelho (Santo André, Brazil)

    Objective: This study aims to find associations between executive function, anxiety, depression, and reactive and anticipatory postural control domains. Background: Cognition and emotional state are…
  • 2022 International Congress

    Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body disease.

    L. Wright, P. Donaghy, D. Burn, J-P. Taylor, J. O'Brien, A. Yarnall, F. Matthews, M. Firbank, A. Thomas, R. Lawson (Newcastle upon Tyne, United Kingdom)

    Objective: To investigate the influence of neuropsychiatric symptoms (NPS) on early cognitive decline in patients with Lewy body disease (LBD). Background: NPS in LBD, including…
  • 2022 International Congress

    Association between longitudinal degeneration of the cholinergic basal forebrain and cognition-relevant cortical areas in early-stage PD

    M. Labrador-Espinosa, J. Silva-Rodríguez, P. Mir, M. Grothe (Sevilla, Spain)

    Objective: To examine whether the association between longitudinal cBF degeneration and cognitive decline in PD is mediated by parallel atrophy of cortical areas. Background: Degeneration…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley